CMS finalizes reimbursement for Exact Sciences' colorectal cancer test
This article was originally published in Clinica
Executive Summary
The US Centers for Medicare and Medicaid Services (CMS) has agreed to reimburse Exact Sciences’ Cologuard DNA stool-based colorectal cancer test at $502 per unit, the price that was requested by the device maker.